Literature Monitoring

Literature Monitoring.

Patient safety means we’re always watching, everywhere.

What are Global Literature Monitoring and Local Literature Monitoring?

Global Literature Monitoring (GLM) of indexed journals through systems like Embase® and Medline®, and Local Literature Monitoring (LLM) of non-indexed local journals, are a key element of any pharmacovigilance system for identifying case reports (ICSRs) and new information from various clinical and non-clinical studies that are relevant to drug safety and efficacy.

Literature Monitoring is more than just a regulatory obligation at Arriello because it provides early insight into safety issues and supports the creation of safety and aggregate reports. It also supports the signal management process, and influences decisions that inform the benefit-risk profile of your product, ultimately helping to protect your patients.

Our Literature Monitoring service.

Arriello provides a complete Literature Monitoring service, including the monitoring of the EMA’s Medical Literature Monitoring (MLM) service, with full text review and assessment of safety information.

Our extensive experience in developing robust, search strategies and the construction of optimized literature queries allows us to search for published studies and information specifically relevant to the safety of your products.

We ensure the efficient assessment and auditable results documentation of any information that may impact study subject safety or require further investigation according to agreed periodicity.

What our clients say about us.

Selected PV Case Studies.

ICSRs, Local literature screening, Regulatory intelligence
Strategic planning for effective results.
Local literature search, ICSR processing, Regulatory intelligence
A bespoke cloud based system.
Local PV, regulatory strategy
23 Countries in two months.